Results 151 to 160 of about 3,975 (165)

Bictegravir-Based Antiretroviral Therapy-Associated Accelerated Hyperglycemia and Diabetes Mellitus. [PDF]

Open Forum Infectious Diseases, 2021
Integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy (ART) is first line for treatment of people with human immunodeficiency virus (PWH). Emerging data suggest the possibility of adverse metabolic effects of these medications.
Nathanial Nolan, Dominic Reeds
exaly   +2 more sources

Total and Unbound Bictegravir Concentrations and Viral Suppression in Cerebrospinal Fluid of Human Immunodeficiency Virus-Infected Patients (Spanish HIV/AIDS Research Network, PreEC/RIS 56) [PDF]

Journal of Infectious Diseases, 2020
We determined total and unbound concentrations of bictegravir (BIC) in cerebrospinal fluid (CSF) in 15 asymptomatic, virologically suppressed patients. The median plasma and CSF total BIC concentrations were 1837.1 ng/mL (interquartile range [IQR], 1237 ...
Sebastián Videla, Daniel Podzamczer, Arkaitz Imaz   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Case Report: Emergent Resistance in a Treatment-Naive Person With Human Immunodeficiency Virus Under Bictegravir-Based Therapy.

Open Forum Infectious Diseases, 2021
Leandro Mena
exaly  

Bictegravir/emtricitabine/tenofovir alafenamide in patients with genotypic NRTI resistance

HIV Medicine, 2023
Stephen D Shafran, Christine A Hughes
exaly  

Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report

Journal of Antimicrobial Chemotherapy, 2022
Sophie Matheron, Gilles Peytavin, Minh Patrick Lê   +2 more
exaly  

High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations

Journal of Antimicrobial Chemotherapy, 2021
Miguel E Quiñones-Mateu, Eric J Arts, Mariano Avino   +2 more
exaly  

HIV-1 non-group M phenotypic susceptibility in vitro to bictegravir and cabotegravir

Journal of Antimicrobial Chemotherapy, 2021
Jean-christophe Plantier, Quentin Le Hingrat, Charlotte Charpentier   +2 more
exaly  

Comparison of the Antiviral Activity of Bictegravir against HIV-1 and HIV-2 Isolates and Integrase Inhibitor-Resistant HIV-2 Mutants.

Antimicrobial Agents and Chemotherapy, 2019
Moussa SEYDI, Geoffrey S. Gottlieb, Vincent H Wu   +2 more
exaly  

Review of Synthetic Routes and Final Forms of Integrase Inhibitors Dolutegravir, Cabotegravir, and Bictegravir

Organic Process Research and Development, 2019
David Hughes
exaly  

Development and validation of LC–MS/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study

Biomedical Chromatography, 2019
Christopher Destache, Pavan Kumar Prathipati, Subhra Mandal   +2 more
exaly